Zainidip in Renal Artery Stenosis
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 149 participants.
Also called NCT02594410
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 149 participants
- Sponsor
- Registry
-
NCT02594410
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02594410. Allocation not applicable; no masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2014-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Zainidip in Renal Artery Stenosis
- Condition
- Hypertension
- Intervention (Device)
- stent
- Intervention (Drug)
- Aspirine
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Lercanidipine
- Lead sponsor
- Lee's Pharmaceutical Limited
Record details
- Record id
cardio:ct-nct02594410- Content hash
7e721076f479059f248d923ef3469ecf2b26a46150e085788a2fc1b15b7e75d1